ATAI Investor Day Presentation Deck slide image

ATAI Investor Day Presentation Deck

Why Are There No Approved Treatments for CIAS? 200+ CIAS treatment trials listed on Clinical trials.gov Amount of investment that is being made in the development of treatments and opportunities for success NIH spend 25 times more on cancer than on schizophrenia Industry investment in clinical trials in 2017 was $71.5 billion, dwarfs government efforts. • There are over 1,000 ongoing clinical trials in cancer for every one in CIAS Progress from phase 1 to the US Food and Drug Administration (FDA) approval is 5.1% for cancer indications, very similar to psychiatry at 6.2%. ● ● ● Curing cancer is more likely to be more personally tangible and may appear to be more morally compelling to investors Keefe RSE. Why are there no approved treatments for Cognitive Impairment in Schizophrenia? World Psychiatry, 2019; Jun; 18(2): 167-168. (PMID: 31059617). 16
View entire presentation